chr17-82085558-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004104.5(FASN):c.4046G>A(p.Arg1349Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,595,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1349W) has been classified as Likely benign.
Frequency
Consequence
NM_004104.5 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FASN | ENST00000306749.4 | c.4046G>A | p.Arg1349Gln | missense_variant | Exon 23 of 43 | 1 | NM_004104.5 | ENSP00000304592.2 | ||
| FASN | ENST00000634990.1 | c.4040G>A | p.Arg1347Gln | missense_variant | Exon 23 of 43 | 5 | ENSP00000488964.1 | |||
| FASN | ENST00000579410.1 | n.103G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152198Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000885 AC: 19AN: 214596 AF XY: 0.0000773 show subpopulations
GnomAD4 exome AF: 0.000184 AC: 265AN: 1442906Hom.: 0 Cov.: 66 AF XY: 0.000173 AC XY: 124AN XY: 716164 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000145 AC: 22AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74346 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4046G>A (p.R1349Q) alteration is located in exon 23 (coding exon 22) of the FASN gene. This alteration results from a G to A substitution at nucleotide position 4046, causing the arginine (R) at amino acid position 1349 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epileptic encephalopathy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1349 of the FASN protein (p.Arg1349Gln). This variant is present in population databases (rs139276176, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FASN-related conditions. ClinVar contains an entry for this variant (Variation ID: 574718). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at